Basic Information
SYNTOMETRINE INJECTION
INJECTION
Regulatory Information
SIN03588P
July 5, 1989
Prescription Only
Therapeutic
INTRAVENOUS, INTRAMUSCULAR
August 10, 2023
June 3, 2025
XG02AC
Company Information
Active Ingredients
Strength: 5 iu/ml
Strength: 0.5 mg/ml
Detailed Information
Contraindications
**4.3 Contraindications** - Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - Pregnancy and labour (induction of labour, first stage labour and second stage labour prior to the delivery of the anterior shoulder) due to the risk of uterine hypertonus and associated foetal complications (see section 4.6 Fertility, pregnancy and lactation – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - Primary or secondary uterine inertia - Severe hypertension, pre-eclampsia, eclampsia - Severe cardiac disorders - Severe hepatic or renal impairment - Occlusive vascular disease - Sepsis
Indication Information
**4.1 Therapeutic indications** - Active management of the third stage of labour (in order to facilitate separation of the placenta and to reduce blood loss) - Prevention and treatment of postpartum haemorrhage associated with uterine atony